Item 5. Market for Registrant’s Common Equity
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Our common stock is listed for trading on NASDAQ Global Select Market under the trading symbol “CLAR”.
Performance Graph
Set forth below is a line graph comparing the yearly percentage change in the cumulative total stockholder return on our common stock to the cumulative total return of the NASDAQ Global Select Market Composite and the Russell 2000 Index for the period commencing on December 31, 2020 and ending on December 31, 2025 (the “Measuring Period”). The graph assumes that the value of the investment in our common stock and the indexes was $100 on December 31, 2020. The yearly change in cumulative total return is measured by dividing (1) the sum of (i) the cumulative amount of dividends for the Measuring Period, assuming dividend reinvestment, and (ii) the change in share price between the beginning and end of the Measuring Period, by (2) the share price at the beginning of the Measuring Period.
Historical stock price performance should not be relied on as indicative of future stock price performance.
Total Return Analysis
2020
2021
2022
2023
2024
2025
Clarus Corporation
$
100.00
$
180.65
$
51.74
$
46.20
$
30.87
$
23.61
The Russell 2000 Index
$
100.00
$
113.69
$
89.18
$
102.64
$
112.93
$
125.68
NASDAQ Global Select Market
$
100.00
$
123.12
$
82.96
$
120.33
$
155.63
$
188.00
Stockholders
On March 2, 2026, the last reported sales price for our common stock was $3.26 per share. As of March 2, 2026, there were 62 holders of record of our common stock.
38
Table of Contents
Dividends
On August 6, 2018, the Company announced that its Board of Directors approved the initiation of a Quarterly Cash Dividend program of $0.025 per share of the Company’s common stock or $0.10 per share on an annualized basis. In 2025, 2024 and 2023, our total Quarterly Cash Dividends were $3,840,000, $3,831,000, and $3,750,000 respectively.
On March 4, 2026, the Company announced that its Board of Directors approved the payment on March 25, 2026 of the Quarterly Cash Dividend to the record holders of shares of the Company’s common stock as of the close of business on March 16, 2026.
The payment of any future Quarterly Cash Dividends will be at the discretion of our Board of Directors and will depend upon, among other things, our results of operations, capital requirements, general business conditions, contractual restrictions on payment of dividends, if any, legal and regulatory restrictions on the payment of dividends, and other factors our Board of Directors deems relevant.
Recent Sales of Unregistered Securities
None.
Recent Purchases of our Registered Equity Securities
On August 1, 2022, the Company announced that its Board of Directors had terminated its $30,000,000 share repurchase program, which still had $10,793,587 available. The program was replaced with a new stock repurchase program that allows the repurchase of up to $50,000,000 of the Company’s outstanding common stock, which still had $42,829,217 available as of December 31, 2025. No repurchases of shares of the Company’s common stock occurred during the three months ended December 31, 2025.
Securities Authorized for Issuance Under Equity Compensation Plans
The following table sets forth certain information regarding our equity plans as of December 31, 2025:
Plan Category
(A)
Number of securities to be issued upon exercise of outstanding, warrants and rights
(B)
Weighted-average exercise price of outstanding options, warrants and rights
(C)
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (A))
Equity compensation plans approved by security holders (1)
4,616,747
$
14.23
7,420,000
Total
4,616,747
$
14.23
7,420,000
(1) Consists of stock options and restricted stock awards issued and issuable under the Amended and Restated 2015 Stock Incentive Plan. There are a total of 1,050,000 restricted stock awards included in column (A) that do not have an exercise price. Excluding these restricted stock awards, the weighted average exercise price of outstanding options, warrants and rights is $9.01.
ITEM 6. [RESERVED]
39
Table of Contents